Axiom Presents “Preventing Failure: How to leverage people and technology to mitigate common FDA audit findings” at Outsourcing in Clinical Trials Southeast 2021

Axiom to Sponsor PharmaVOICE Virtual Panel ‘The Critical Importance of ePRO (electronic Patient Reported Outcomes) in Clinical Research in Our Challenging and Evolving Times’

Axiom COVID-19, Events, Press Release

TORONTO, May 12, 2020 (GLOBE NEWSWIRE) — On May 14, 2020 Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, will be participating in and sponsoring a PharmaVOICE virtual panel event.

The event will bring together an esteemed panel of experts in clinical development/operations and data management. All panel members are currently deeply engaged in complex global ePRO studies.

The group will discuss the critical importance of ePRO/eCOA data in today’s clinical research and the potential that it provides in terms of understanding key aspects of patient data.  Discussion will include points on managing critical endpoints in ePRO data and best practices in managing ePRO data.

The event will be moderated by Taren Grom, Editor of PharmaVOICE. Panelists include Dr. Paul-André de Lame, M.D., Founder of Anabase International Corp., Naomi Waithira, Head of Data Management, Mahidol Oxford Research Unit, University of Oxford, John Woock, Ph.D., Chief Marketing Officer at Axonics Modulation Technologies, Inc., and Andrew Schachter, Axiom’s Founder & CEO.

“ePRO continues to exponentially grow as a tool to capture key data directly from subjects participating in clinical studies. We are looking forward to a deep discussion on this topic. As capturing data in the age of COVID-19 has required the industry to adapt how clinical trials are conducted, the panel will also discuss data collection challenges that require our adaption and the key role of ePRO in meeting the needs of data and clinical monitoring,” shared Andrew Schachter.

To register, please visit:

See on GlobeNewswire